The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

The global market for prosthetic heart valve is forecasted to attain USD 15,294.6 million by 2025, expanding at 7.5% CAGR to reach USD 31,522.6 million by 2035. In 2024, the revenue of prosthetic ...

This allows for precision care with less pain, fewer complications and quicker recovery times. Recognised for his ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) ...

St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

The Harmony Transcatheter Pulmonary Valve is a cutting-edge valve-replacement procedure, where an expandable valve was ...

Cape Fear Valley Medical Center has earned its fourth consecutive C grade in patient safety from a national nonprofit ...